Riskpilot← Back to searchSign inGet full accessFALKETIND HELSE AS
ASActiveOrg 922160635Kantarellringen 14B, 2033 ÅsgreinaPhysiotherapy activities · NACE 8695Est. 20192 employees
Revenue 2024
NOK 1,7M
+176% vs 2023
EBITDA margin
-13.5%
-55% vs 2023
Equity ratio
2.5%
Financial strength
Net profit 2024
NOK -146K
-1% vs 2023
| Revenue | NOK 1,7M | +176% |
| EBITDA | NOK -223K | -55% |
| Net profit | NOK -146K | -1% |
| Total assets | NOK 1,5M | +412% |
| Equity | NOK 37K | -80% |
| Employees | 2 | — |
Legal name
FALKETIND HELSE AS
Org number
922160635
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
4. februar 2019
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap eller daglig leder og styrets leder i fellesskap.
Company purpose
Helhetfokusert fysioterapi og kognitiv terapi individuell behandling og kurs i blant annet behandling og håndtering av insomni, smerteforståelse og smertemestring, depresjon og angstmestring. Arbeidshelse helsefremmende og forebyggende prosesser hos bedrifter herunder kursing og veiledning av ansatte og ledere.
Address
Kantarellringen 14B, 2033 Åsgreina
Phone
+4745966183
Email
ingunn@falketindhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 673 | 1 185 | 1 075 | 599 | 1 656 |
| Staff expenses | −474 | −742 | −752 | −498 | −1 320 |
| EBITDA | 44 | 263 | 105 | −144 | −223 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −15 |
| EBIT | 44 | 263 | 105 | −144 | −238 |
| Net financials | −0 | 0 | −0 | −0 | 10 |
| Profit before tax | 44 | 263 | 105 | −144 | −227 |
| Tax | 8 | 58 | 23 | −0 | −82 |
| Net profit | 36 | 205 | 82 | −144 | −146 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 235 | 492 | 487 | 292 | 1 494 |
| Equity | 40 | 245 | 327 | 183 | 37 |
| Long-term debt | 0 | 1 | 0 | 0 | 0 |
| Short-term debt | 195 | 247 | 160 | 109 | 1 456 |
| Total debt | 195 | 247 | 160 | 109 | 1 456 |
EBITDA margin
-13.5%
This company
15.8%
Market median
-185% vs market
20202024
Equity ratio
2.5%
This company
38.2%
Market median
-93% vs market
20202024
Return on equity
-389.1%
This company
18.4%
Market median
-2215% vs market
20202024
Net profit margin
-8.8%
This company
8.1%
Market median
-209% vs market
20202024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20202024
Debt / equity
38.88×
This company
0.62×
Market median
-6171% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IS Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ingunn Fysio As
FALKETIND HELSE AS Board members of FALKETIND HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingunn Storholm Nagel-Dahl | Chief Executive Officer | 0 companies |
| Torgeir Stavrum Aas | Chairman | 0 companies |